JP2001503609A5 - - Google Patents

Download PDF

Info

Publication number
JP2001503609A5
JP2001503609A5 JP1998502819A JP50281998A JP2001503609A5 JP 2001503609 A5 JP2001503609 A5 JP 2001503609A5 JP 1998502819 A JP1998502819 A JP 1998502819A JP 50281998 A JP50281998 A JP 50281998A JP 2001503609 A5 JP2001503609 A5 JP 2001503609A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998502819A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001503609A (ja
JP4173549B2 (ja
Filing date
Publication date
Priority claimed from SE9602496A external-priority patent/SE9602496D0/xx
Application filed filed Critical
Publication of JP2001503609A publication Critical patent/JP2001503609A/ja
Publication of JP2001503609A5 publication Critical patent/JP2001503609A5/ja
Application granted granted Critical
Publication of JP4173549B2 publication Critical patent/JP4173549B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP50281998A 1996-06-20 1997-06-18 コアグラーゼ陰性ブドウ球菌に由来する、新規フィブリノーゲン結合たん白質 Expired - Fee Related JP4173549B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9602496A SE9602496D0 (sv) 1996-06-20 1996-06-20 Method and means for producing a fibrinogen binding protein and its use in biotechnology
SE9602496-3 1996-06-20
PCT/SE1997/001091 WO1997048727A1 (en) 1996-06-20 1997-06-18 New fibrinogen binding protein originating from coagulase-negative staphylococcus

Publications (3)

Publication Number Publication Date
JP2001503609A JP2001503609A (ja) 2001-03-21
JP2001503609A5 true JP2001503609A5 (enExample) 2005-02-10
JP4173549B2 JP4173549B2 (ja) 2008-10-29

Family

ID=20403140

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50281998A Expired - Fee Related JP4173549B2 (ja) 1996-06-20 1997-06-18 コアグラーゼ陰性ブドウ球菌に由来する、新規フィブリノーゲン結合たん白質

Country Status (10)

Country Link
US (2) US6733758B1 (enExample)
EP (1) EP0922056B1 (enExample)
JP (1) JP4173549B2 (enExample)
AT (1) ATE316979T1 (enExample)
AU (1) AU3282597A (enExample)
CA (1) CA2294433A1 (enExample)
DE (1) DE69735207T2 (enExample)
ES (1) ES2258280T3 (enExample)
SE (1) SE9602496D0 (enExample)
WO (1) WO1997048727A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6685943B1 (en) 1997-01-21 2004-02-03 The Texas A&M University System Fibronectin binding protein compositions and methods of use
US6380370B1 (en) * 1997-08-14 2002-04-30 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
AU1537699A (en) * 1997-11-26 1999-06-15 Bioresearch Ireland a division of Eolas - The Irish Science and Technology Agency Extracellular matrix-binding proteins from (staphylococcus aureus)
WO2000012131A1 (en) * 1998-08-31 2000-03-09 Inhibitex, Inc. Multicomponent vaccines
US6635473B1 (en) * 1998-08-31 2003-10-21 The Provost Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin Polypeptides and polynucleotides from coagulase-negative staphylococci
CA2341177A1 (en) * 1998-08-31 2000-03-09 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
US6692739B1 (en) 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
US6703025B1 (en) 1998-08-31 2004-03-09 Inhibitex, Inc. Multicomponent vaccines
US20040038327A1 (en) * 1999-08-31 2004-02-26 Foster Timothy J. Antibodies to polypeptides from coagulase-negative staphylococci
EP2320233A1 (en) 2001-06-15 2011-05-11 Inhibitex, Inc. Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
CA2478029A1 (en) * 2002-03-05 2003-09-18 Inhibitex, Inc. Monoclonal and polyclonal antibodies recognizing coagulase-negative staphylococcal proteins
CA2517439C (en) 2003-03-07 2013-07-23 Wyeth Holdings Corporation Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections
ES2730275T3 (es) 2004-09-22 2019-11-11 Glaxosmithkline Biologicals Sa Composición inmunógena para uso en vacunación contra estafilococos
KR101541383B1 (ko) 2006-03-30 2015-08-03 글락소스미스클라인 바이오로지칼즈 에스.에이. 면역원성 조성물
WO2007127339A2 (en) * 2006-04-26 2007-11-08 Tyco Healthcare Group Lp Multi-stage microporation device
SI2445522T1 (sl) 2009-06-22 2017-10-30 Wyeth Llc Imunogeni sestavki antigenov Staphylococcusa aureusa
CA2768204A1 (en) 2009-07-15 2011-01-20 Aimm Therapeutics B.V. Gram-positive bacteria specific binding compounds
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
KR20230031322A (ko) 2020-06-27 2023-03-07 크레센타 바이오사이언시즈 세포 물질대사를 조정하는 화합물의 조성물 및 사용 방법
US12138243B2 (en) 2021-12-31 2024-11-12 Crescenta Biosciences Antiviral use of FABP4 modulating compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3583987D1 (de) 1984-11-06 1991-10-10 Thomae Gmbh Dr K Antibiotisches polypeptid, verfahren zu seiner herstellung und seine verwendung.
ATE95187T1 (de) * 1988-07-15 1993-10-15 Thomae Gmbh Dr K Verfahren zur gewinnung, isolierung und reinigung von epidermin.
US5055455A (en) * 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
US5571511A (en) * 1990-10-22 1996-11-05 The U.S. Government Broadly reactive opsonic antibodies that react with common staphylococcal antigens
EP0621875B1 (en) * 1992-09-21 2002-03-27 Alfa-Laval Agri International Ab Fibrinogen binding protein
IL109410A0 (en) * 1993-04-30 1994-07-31 Ell Lilly & Company Fema gene of staphylococcus epidermidis, fema protein, and vectors and microorganisms comprising the fema gene
US6107068A (en) * 1995-12-22 2000-08-22 The University Of British Columbia Coenzyme A disulfide reductase, and inhibitors thereof useful as antimicrobial agents

Similar Documents

Publication Publication Date Title
JP2000501771A5 (enExample)
JP2000501599A5 (enExample)
JP2000501018A5 (enExample)
JP2000500076A5 (enExample)
JP2000501324A5 (enExample)
JP2000500055A5 (enExample)
JP2000500026A5 (enExample)
JP2000507939A5 (enExample)
JP2000501825A5 (enExample)
JP2000501338A5 (enExample)
JP2001503889A5 (enExample)
JP2000500874A5 (enExample)
JP2000506123A5 (enExample)
JP2001502215A5 (enExample)
JP2000501774A5 (enExample)
JP2000503848A5 (enExample)
JP2000500912A5 (enExample)
JP2000501876A5 (enExample)
JP2000501744A5 (enExample)
JP2000501229A5 (enExample)
JP2000500857A5 (enExample)
JP2000502714A5 (enExample)
JP2000501569A5 (enExample)
JP2000500318A5 (enExample)
JP2000500184A5 (enExample)